DEUTSCHE BANK AG\ - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$121,000
-51.4%
13,885
-10.7%
0.00%
Q4 2021$249,000
-8.5%
15,543
+5.3%
0.00%
Q3 2021$272,000
+27.7%
14,763
-3.0%
0.00%
Q2 2021$213,000
+3.9%
15,215
+9.0%
0.00%
Q1 2021$205,000
-30.3%
13,953
-8.2%
0.00%
Q4 2020$294,000
+219.6%
15,192
+83.6%
0.00%
Q3 2020$92,000
-9.8%
8,276
+10.0%
0.00%
Q2 2020$102,000
+264.3%
7,524
+116.9%
0.00%
Q1 2020$28,000
-63.2%
3,469
-56.3%
0.00%
Q4 2019$76,000
+153.3%
7,930
+174.9%
0.00%
Q3 2019$30,000
-65.9%
2,885
-62.7%
0.00%
Q2 2019$88,000
-30.7%
7,737
-22.3%
0.00%
Q1 2019$127,000
+89.6%
9,954
-9.8%
0.00%
Q4 2018$67,000
-82.5%
11,031
-69.7%
0.00%
Q3 2018$382,000
+13.0%
36,408
+57.4%
0.00%
Q2 2018$338,000
+207.3%
23,124
+195.4%
0.00%
Q1 2018$110,000
-29.0%
7,827
-41.1%
0.00%
Q4 2017$155,00013,2930.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders